|
SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias
|
Feb 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium study.
|
Mar 2012
|
Leuk Res
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab
|
Jan 2017
|
Ann Hematol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Serial assessment of suspected myelodysplastic syndromes: significance of flow cytometric findings validated by cytomorphology, cytogenetics, and molecular genetics
|
Aug 2012
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study
|
Jan 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Self-reported sleep disturbance and survival in myelodysplastic syndromes
|
Mar 2017
|
Br J Haematol
|
myelodysplastic syndromes (MDS)
|
|
Self-perception of symptoms of anemia and fatigue before and after blood transfusions in patients with myelodysplastic syndromes
|
Nov 2014
|
Eur J Oncol Nurs
|
myelodysplastic syndromes (MDS)
|
|
Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients
|
Jan 2016
|
Immunobiology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Selective splenic artery embolization for the treatment of thrombocytopenia and hypersplenism in paroxysmal nocturnal hemoglobinuria
|
Mar 2014
|
J Hematol Oncol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Secondary Myelodysplastic Syndrome and Leukemia in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
|
Jul 2020
|
Blood
|
aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH)
|
